Hirschsprung Disease Audience Q&A with Dr. Marc Levitt podcast cover art
10 Views
0 Likes
0 Shares
0 Comments

Colorectal Channel

View profile →

Hirschsprung Disease Audience Q&A with Dr. Marc Levitt

Published:

Topic overview

Dr. Marc Levitt addresses the role of Botox injections in managing post-operative Hirschsprung disease, particularly for infants under one year with high anal sphincter tone causing enterocolitis despite successful pull-through surgery. He emphasizes ruling out anatomic issues like retained cuff or transition zone before using Botox in older patients.

Key takeaways

  • Botox targets high anal sphincter tone in post-operative Hirschsprung patients, especially infants who instinctively hold stool, preventing enterocolitis.
  • Before Botox, rule out anatomic issues (retained cuff, stricture, twist) and pathologic problems (transition zone, nerve hypertrophy >40 microns).
  • In infants <1 year, Botox may prevent enterocolitis after technically successful pull-through; consider empiric use in prospective trials.
  • Repeated Botox need beyond 1-2 doses in patients >1 year suggests missed anatomic or pathologic problem requiring further workup.
  • Demand pathologists measure nerve caliber on biopsies—nerves >40 microns indicate transition zone pull-through, not true aganglionosis resolution.

Keywords

Hashtags

Transcript

Click "Show Transcript" to view the full text (11605 characters)

Comments

Loading comments...